Enhanced expression of dopamine D1 and glutamate NMDA receptors in dopamine D4 receptor knockout mice

Journal of Molecular Neuroscience

Volumn 22, Issue 3, 2004, Pages 167-177

  Gan, Lu ^a,b   Falzone, Tomas L ^c   Zhang, Kehong ^a,b   Rubinstein, Marcelo ^c   Baldessarini, Ross J ^a,b   Tarazi, Frank I ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Autoradiography; Caudate putamen; D4 receptor; Dopamine receptors; Genetic knockout; Glutamate receptors; Mutant mice

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 4 RECEPTOR; GLUTAMATE RECEPTOR; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; AMINO ACID RECEPTOR AFFECTING AGENT; AMPA RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; DRD4 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN DEVELOPMENT; CHEMICAL LABELING; CONTROLLED STUDY; FOREBRAIN; GENE FUNCTION; HIPPOCAMPUS; IMMUNOCHEMISTRY; KNOCKOUT MOUSE; MALE; MOUSE; MOUSE MUTANT; NEUROCHEMISTRY; NEUROPHYSIOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; PROTEIN BINDING; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR UPREGULATION; STATISTICAL SIGNIFICANCE; WILD TYPE; ADAPTATION; ANIMAL; BINDING COMPETITION; BRAIN; BRAIN LEVEL; DRUG EFFECT; GENETICS; METABOLISM; NEOSTRIATUM; RADIOASSAY; SYNAPTIC TRANSMISSION; UPREGULATION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; AUTORADIOGRAPHY; BINDING, COMPETITIVE; BRAIN; BRAIN CHEMISTRY; DOPAMINE AGENTS; EXCITATORY AMINO ACID AGENTS; HIPPOCAMPUS; MALE; MICE; MICE, KNOCKOUT; NEOSTRIATUM; NUCLEUS ACCUMBENS; RADIOLIGAND ASSAY; RECEPTORS, AMPA; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; RECEPTORS, KAINIC ACID; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTIC TRANSMISSION; UP-REGULATION;

EID: 2942541043     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:22:3:167     Document Type: Article

References (43)

1. 4 dopamine receptor protein in the CNS using antireceptor antisera. Brain Res. 752, 26-34.
2. Baldessarini R. J. and Tarazi F. I. (1996) Brain dopamine receptors: A primer on their current status, basic and clinical. Harvard Rev. Psychiatry 3, 301-325.
3. 4 dopamine receptor gene and measures of novelty-seeking. Nat. Genet. 12, 81-84.
4. Bucan M. and Abel T. (2002) The mouse: genetics meets behavior. Nat. Rev. Genet. 3, 114-123.
5. Carlsson M. and Carlsson A. (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease. Trends Neurosci. 13, 272-276.
6. Carlsson A., Waters N., Holm-Waters S., Tedroff J., Nilsson M., and Carlsson M.L. (2001) Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Ann. Rev. Pharmacol. Toxicol. 41, 237-260.
7. 1 and N-methyl-D-aspartate receptors. J. Pharmacol. Exp. Ther. 259, 1064-1072.
8. 4 receptor in the mouse brain. J. Neurosci. Res. 59, 202-208.
9. 4 dopamine receptor in rat brain with sequence-specific antibodies. Mol. Brain Res. 45, 1-12.
10. 4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J. Neurosci. 19, 9550-9556.
11. 4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nat. Genet. 12, 78-80.
12. 4 receptors results in enhanced reactivity to unconditioned, but not conditioned, fear. Eur. J. Neurosci. 15, 158-164.
13. 1 receptors and DARPP-32. J. Neurophysiol. 88, 3010-3020.
14. Florijn W. J., Tarazi F.I., and Creese I. (1997) Dopamine receptor subtypes: differential regulation following 8 months treatment with antipsychotic drugs. J. Pharmacol. Exp. Ther. 280, 561-569.
15. Halpain S., Girault J. A., and Greengard P. (1990) Activation of NMDA receptors induce dephosphorylaton of DARPP-32 in rat striatal slices. Nature 343, 369-372.
16. 2 receptor selective antagonists: electrophysiological and behavioral studies. Synapse 17, 43-61.
17. Kebabian J. W., Tarazi F. I., Kula N. S., and Baldessarini R. J. (1997) Compounds selective for dopamine receptor subtypes. Drug Discovery Today 2, 333-340.
18. 2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression. Neuroscience 66, 903-113.
19. 2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission. Neuron 35, 1111-1122.
20. 4-selective radioligands. Eur. J. Pharmacol. 367, 139-142
21. 4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol. Psychiatry 1, 128-131.
22. 4 (DRD4) gene. Hum. Mol. Genet. 6, 767-773.
23. 4 receptors in GABAergic neurons of the primate brain. Nature 381, 245-248.
24. Neve K. A. and Neve R. L. (1997) The Dopamine Receptors, Humana Press, Totowa, NJ.
25. 4 receptor-deficient mice display cortical hyperexcitability. J. Neurosci. 21, 3756-3763.
26. 4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 90, 991-1001.
27. Singh N. A., Bush L. G., Gibb J. W., and Hanson G. R. (1990) Dopamine-mediated changes in central nervous system neurotensin systems: a role for NMDA receptors. Eur. J. Pharmacol. 187, 337-344.
28. Surmeier D. J., Song W. J., and Yan Z. (1996) Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J. Neurosci. 16, 6579-6591.
29. 4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD). Mol. Psychiatry 3, 38-41.
30. 4 receptors: significance for molecular psychiatry at the millennium. Mol. Psychiatry 4, 529-538.
31. Tarazi F. I. and Baldessarini R. J. (1999b) Regional localization of dopamine and glutamate receptor subtypes in striatolimbic brain regions. J. Neurosci. Res. 55, 401-410.
32. 4 receptors in rat forebrain. Int. J. Dev. Neurosci. 18, 29-37.
33. Tarazi F. I., Baldessarini R. J., Kula N. S., and Zhang K. (2003) Long-term effects of olanzapine, risperidone, and quetiapine on ionotropic glutamate receptor types: Implications for antipsychotic drug treatment. J. Pharmacol. Exp. Ther. 306, 1145-1151.
34. Tarazi F. I., Campbell A., Yeghiayan S. K., and Baldessarini R. J. (1998) Localization of glutamate receptor subtypes in caudate-putamen and nucleus accumbens septi: Comparison of NMDA, AMPA and kainate receptors. Synapse 30, 227-235.
35. Tarazi F. I., Florijn W. J., and Creese I. (1996) Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics. Psychopharmacology 128, 371-379.
36. 4 receptors in rat forebrain. NeuroReport 8, 3423-3426.
37. 4-like dopamine receptors. Neuropsychopharmacology 17, 186-196.
38. Tarazi F. I., Zhang K., and Baldessarini R. J. (2001) Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: Implications for antipsychotic drug treatment. J. Pharmacol. Exp. Ther. 297, 711-717.
39. 4 receptor gene with high affinity for the antipsychotic clozapine. Nature 350, 614-619.
40. 4 receptor variants in the human population. Nature 358, 149-152.
41. Wullner U., Testa C.M., Catania M. V., Young A. B., and Penney J. B. (1994) Glutamate receptors in striatum and substantia nigra: Effects of medial forebrain bundle lesions. Brain Res. 645, 98-102.
42. 4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions. Psychopharmacology 161, 100-106.
43. 4 receptors in motor hyperactivity induced by neonatal 6-hydroxydopamine lesions in rats. Neuropsychopharmacology 25, 624-632.